The compliance process at pharmaceutical manufacturers is a complicated and prone to errors because many still use paper-based systems to record manufacturing steps. These paper records are reviewed by FDA auditors to ensure that guidelines were followed, but they are prone to errors, often leading to warnings. This results in higher costs and slower manufacturing. […]
© 2023 TechCrunch. All rights reserved. For personal use only.
Source: TECCRUCH
スポンサーリンク
Leucine makes drug manufacturing compliance less onerous
IT起業ニュース
コメント